{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:03:58Z","timestamp":1793246638557,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008316","name":"Baden-W\u00fcrttemberg Foundation","doi-asserted-by":"publisher","award":["BWST_ISF2020-46"],"award-info":[{"award-number":["BWST_ISF2020-46"]}],"id":[{"id":"10.13039\/100008316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["KO 1674\/28-1"],"award-info":[{"award-number":["KO 1674\/28-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["MU1457\/17-1"],"award-info":[{"award-number":["MU1457\/17-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001661","name":"Universit\u00e4t Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114374","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:58:23Z","timestamp":1762124303000},"page":"114374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPs\u03b1 as a therapeutic strategy for Alzheimer's disease"],"prefix":"10.1016","volume":"389","author":[{"given":"Lena","family":"Rehra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Erdinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelia","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Baltissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"M\u00fchlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Eisenzapf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Banicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Bengelsdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Korte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114374_bb0005","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s00415-024-12314-3","article-title":"Genetic forms of tauopathies: inherited causes and implications of Alzheimer\u2019s disease-like TAU pathology in primary and secondary tauopathies","volume":"271","author":"Langerscheidt","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF01273157","article-title":"Synaptic pathology in Alzheimer\u2019s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele","volume":"103","author":"Blennow","year":"1996","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jconrel.2025.114374_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"In vivo measurement of widespread synaptic loss in Alzheimer\u2019s disease with SV2A PET","volume":"16","author":"Mecca","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2025.114374_bb0045","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1212\/WNL.0000000000009818","article-title":"In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment","volume":"95","author":"Vanhaute","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2025.114374_bb0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/0271678X231153730","article-title":"In vivo synaptic density loss correlates with impaired functional and related structural connectivity in Alzheimer\u2019s disease","volume":"43","author":"Zhang","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2025.114374_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114374_bb0060","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","article-title":"Targeting synapse function and loss for treatment of neurodegenerative diseases","volume":"23","author":"Dejanovic","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114374_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-025-01094-7","article-title":"Synapse vulnerability and resilience across the clinical spectrum of dementias","volume":"21","author":"Taddei","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","article-title":"Not just amyloid: physiological functions of the amyloid precursor protein family","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0085","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1523\/JNEUROSCI.4130-15.2016","article-title":"Amyloid precursor protein protects neuronal network function after hypoxia via control of voltage-gated calcium channels","volume":"36","author":"Hefter","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00401-014-1368-x","article-title":"Acute function of secreted amyloid precursor protein fragment APPsalpha in synaptic plasticity","volume":"129","author":"Hick","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011506118","article-title":"APPsalpha rescues impaired Ca2+ homeostasis in APP- and APLP2-deficient hippocampal neurons","volume":"118","author":"Ludewig","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.jconrel.2025.114374_bb0100","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1523\/JNEUROSCI.1826-18.2019","article-title":"Glutamate receptor trafficking and protein synthesis mediate the facilitation of LTP by secreted amyloid precursor protein-alpha","volume":"39","author":"Mockett","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnmol.2017.00030","article-title":"Therapeutic potential of secreted amyloid precursor protein APPsalpha","volume":"10","author":"Mockett","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0110","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.ymthe.2022.03.024","article-title":"The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer\u2019s disease","volume":"30","author":"Musardo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114374_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14336\/AD.2015.0907","article-title":"The neuroprotective properties of the amyloid precursor protein following traumatic brain injury","volume":"7","author":"Plummer","year":"2016","journal-title":"Aging Dis."},{"key":"10.1016\/j.jconrel.2025.114374_bb0120","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798335","article-title":"Distinct in vivo roles of secreted APP ectodomain variants APPsalpha and APPsbeta in regulation of spine density, synaptic plasticity, and cognition","volume":"37","author":"Richter","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2025.114374_bb0125","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.1026-07.2007","article-title":"The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice","volume":"27","author":"Ring","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nbd.2008.04.011","article-title":"Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory","volume":"31","author":"Taylor","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2025.114374_bb0135","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/emboj.2011.119","article-title":"APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP","volume":"30","author":"Weyer","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2025.114374_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jnc.12391","article-title":"The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96-110","volume":"128","author":"Corrigan","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114374_bb0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2012.02.045","article-title":"Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury","volume":"1451","author":"Corrigan","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2025.114374_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1471-4159.2012.07761.x","article-title":"sAPPalpha rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury","volume":"122","author":"Corrigan","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114374_bb0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2051-5960-2-36","article-title":"Comparative analysis of single and combined APP\/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPsalpha expression","volume":"2","author":"Weyer","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jconrel.2025.114374_bb0160","doi-asserted-by":"crossref","first-page":"1106176","DOI":"10.3389\/fncel.2023.1106176","article-title":"APPsalpha rescues CDK5 and GSK3beta dysregulation and restores normal spine density in tau transgenic mice","volume":"17","author":"Baltissen","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0165","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.2200-21.2022","article-title":"APPsalpha rescues tau-induced synaptic pathology","volume":"42","author":"Bold","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-015-1498-9","article-title":"Viral gene transfer of APPsalpha rescues synaptic failure in an Alzheimer\u2019s disease mouse model","volume":"131","author":"Fol","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13041-018-0348-9","article-title":"Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Tan","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.jconrel.2025.114374_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107670","article-title":"A C-terminal peptide from secreted amyloid precursor protein-alpha enhances long-term potentiation in rats and a transgenic mouse model of Alzheimer\u2019s disease","volume":"157","author":"Morrissey","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2025.114374_bb0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","article-title":"Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model","volume":"118","author":"Wirths","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2353\/ajpath.2006.060002","article-title":"Alzheimer\u2019s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits","volume":"169","author":"Schindowski","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0195","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1093\/hmg\/ddv268","article-title":"Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like tau pathology","volume":"24","author":"Burlot","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2025.114374_bb0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","article-title":"Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau","volume":"48","author":"Jicha","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2025.114374_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2016.08.040","article-title":"Delivery of copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes","volume":"512","author":"Tremmel","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114374_bb0210","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1002\/anie.201102572","article-title":"Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters","volume":"50","author":"Mandal","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2025.114374_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303654","article-title":"Oral delivery of the vancomycin derivative FU002 by a surface-modified liposomal Nanocarrier","volume":"13","author":"Werner","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114374_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21873\/anticanres.13103","article-title":"Cell-penetrating peptide-coated liposomes for drug delivery across the blood-brain barrier","volume":"39","author":"Yuan","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jconrel.2025.114374_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","article-title":"Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier","volume":"55","author":"Lajoie","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0235","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114374_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114799","article-title":"Immunoliposomes - a new therapeutic option to treat SynGAP1-associated epilepsy","volume":"214","author":"Wienken","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114374_bb0245","article-title":"Liposomes containing tetraether lipids and cell- penetrating peptides as platform technology for oral delivery of peptides: a comparative study on GLP-1 analogs","volume":"e70010","author":"Herbster","year":"2025","journal-title":"Nano Sel"},{"key":"10.1016\/j.jconrel.2025.114374_bb0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12987-023-00501-9","article-title":"Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line","volume":"20","author":"Ozgur","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2025.114374_bb0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(95)00148-4","article-title":"The influence of cytokines on the integrity of the blood-brain barrier in vitro","volume":"64","author":"de Vries","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0265","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03401701","article-title":"TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier","volume":"3","author":"Fiala","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0270","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114374_bb0275","article-title":"Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier","volume":"56","author":"Werner","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.114374_bb0280","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1523\/JNEUROSCI.0180-14.2014","article-title":"Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain","volume":"34","author":"Baumkotter","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0285","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1523\/JNEUROSCI.1875-16.2017","article-title":"APLP1 is a synaptic cell adhesion molecule, supporting maintenance of dendritic spines and basal synaptic transmission","volume":"37","author":"Schilling","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0290","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/sj.emboj.7600824","article-title":"Homo- and heterodimerization of APP family members promotes intercellular adhesion","volume":"24","author":"Soba","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2025.114374_bb0295","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fncel.2014.00410","article-title":"Shedding of APP limits its synaptogenic activity and cell adhesion properties","volume":"8","author":"Stahl","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0300","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0169-328X(96)00036-8","article-title":"Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer\u2019s beta-amyloid precursor","volume":"40","author":"Barger","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2025.114374_bb0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","article-title":"Functions of Abeta, sAPPalpha and sAPPbeta\u202f: similarities and differences","volume":"120","author":"Chasseigneaux","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114374_bb0310","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcn.2010.04.007","article-title":"sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress","volume":"44","author":"Copanaki","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0315","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.67051882.x","article-title":"Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain","volume":"67","author":"Furukawa","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114374_bb0320","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1007\/s12035-015-9501-y","article-title":"Modulation of BAG3 expression and proteasomal activity by sAPPalpha does not require membrane-tethered Holo-APP","volume":"53","author":"Kundu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0896-6273(93)90315-I","article-title":"Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein","volume":"10","author":"Mattson","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2025.114374_bb0330","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nlm.2016.08.002","article-title":"Secreted amyloid precursor protein-alpha can restore novel object location memory and hippocampal LTP in aged rats","volume":"138","author":"Xiong","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.jconrel.2025.114374_bb0335","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","article-title":"Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease","volume":"54","author":"Holstege","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2025.114374_bb0340","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2025.114374_bb0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Suh","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2025.114374_bb0350","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.conb.2021.09.003","article-title":"Secretases in Alzheimer\u2019s disease: novel insights into proteolysis of APP and TREM2","volume":"72","author":"Lichtenthaler","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0355","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.15252\/emmm.201707672","article-title":"An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function","volume":"9","author":"Schlepckow","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0360","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1523\/JNEUROSCI.0511-21.2022","article-title":"Neurexin-beta mediates the synaptogenic activity of amyloid precursor protein","volume":"42","author":"Cvetkovska","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0365","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jnc.13351","article-title":"Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3beta signaling pathway","volume":"135","author":"Deng","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114374_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065920","article-title":"Soluble alpha-APP (sAPPalpha) regulates CDK5 expression and activity in neurons","volume":"8","author":"Hartl","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jconrel.2025.114374_bb0375","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41583-024-00829-7","article-title":"Gene therapy for CNS disorders: modalities, delivery and translational challenges","volume":"25","author":"Gao","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0380","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.3233\/JAD-240545","article-title":"Growth factor gene therapy for Alzheimer\u2019s disease","volume":"101","author":"Tuszynski","year":"2024","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jconrel.2025.114374_bb0385","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1186\/s12967-024-05661-2","article-title":"Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside","volume":"22","author":"Xu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0390","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41591-025-03822-4","article-title":"Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1\/2 trial","volume":"31","author":"Eichler","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0395","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(17)30169-2","article-title":"Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1\/2 clinical trial","volume":"16","author":"Tardieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2025.114374_bb0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119142","article-title":"Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection","volume":"270","author":"Huang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0410","doi-asserted-by":"crossref","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"Korbelin","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0415","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2025.01.021","article-title":"An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism","volume":"379","author":"Luo","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114374_bb0420","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41434-025-00517-w","article-title":"Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity","volume":"32","author":"Gumusgoz","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114374_bb0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fneng.2013.00007","article-title":"The blood-brain barrier: an engineering perspective","volume":"6","author":"Wong","year":"2013","journal-title":"Front Neuroeng"},{"key":"10.1016\/j.jconrel.2025.114374_bb0430","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1039\/D3TB01866K","article-title":"Multifunctional gene delivery vectors containing different liver-targeting fragments for specifically transfecting hepatocellular carcinoma (HCC) cells","volume":"11","author":"Cheng","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2025.114374_bb0435","doi-asserted-by":"crossref","first-page":"11081","DOI":"10.1038\/s41598-023-37280-0","article-title":"Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides","volume":"13","author":"Reveret","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114374_bb0440","doi-asserted-by":"crossref","first-page":"2261509","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2025.114374_bb0445","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114374_bb0450","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2025.114374_bb0455","doi-asserted-by":"crossref","first-page":"eads3204","DOI":"10.1126\/science.ads3204","article-title":"Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA","volume":"389","author":"Pizzo","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114374_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-brain barrier transport of transferrin receptor-targeted nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114374_bb0465","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.xphs.2024.03.017","article-title":"Antibody conjugated nano-enabled drug delivery systems against brain tumors","volume":"113","author":"Topcu","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0470","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1021\/bi1019429","article-title":"Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9","volume":"50","author":"Ziegler","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2025.114374_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106054","article-title":"Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model","volume":"168","author":"Froslev","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0480","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/156720511796717230","article-title":"Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?","volume":"8","author":"Belarbi","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jconrel.2025.114374_bb0485","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107471","article-title":"Loss of all three APP family members during development impairs synaptic function and plasticity, disrupts learning, and causes an autism-like phenotype","volume":"40","author":"Steubler","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2025.114374_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107159","article-title":"Archaeosomal nanocarriers improve pharmacokinetics and bioavailability of vancomycin after oral administration","volume":"212","author":"Sedlmayr","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114374_bb0495","first-page":"4","article-title":"Overcoming the mucosal barrier: tetraether lipid-stabilized liposomal nanocarriers decorated with cell-penetrating peptides enable oral delivery of vancomycin","author":"Uhl","year":"2021","journal-title":"Adv Ther-Germany"},{"key":"10.1016\/j.jconrel.2025.114374_bb0500","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0196-9781(02)00192-4","article-title":"Approaches to radioiodination of insect neuropeptides","volume":"23","author":"Crim","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2025.114374_bb0505","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ab.2012.10.010","article-title":"Stain-free technology as a normalization tool in Western blot analysis","volume":"433","author":"Gurtler","year":"2013","journal-title":"Anal. Biochem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:38:30Z","timestamp":1781325510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":101,"alternative-id":["S0168365925009885"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114374","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPs\u03b1 as a therapeutic strategy for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114374"}}